class name | count |
---|---|
Liliopsida | 8 |
class name | count |
---|---|
Zingiberaceae | 8 |
br08003 Category | # of metabolite |
---|---|
Diarylheptanoids | 1 |
br08003 Category | KEGG ID | KNApSAcK ID |
---|---|---|
Diarylheptanoids | C10443 | C00002731 |
KCF-S ID | # of metabolite |
---|---|
No. 3613 | 3 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
figure |
---|---|---|---|---|---|---|---|
C00002731
![]() |
Letestuianin A
|
CHEMBL478742
|
No. 3613 |
![]() |
|||
C00044863
![]() |
Letestuianin B
|
CHEMBL518119
|
No. 3613 |
![]() |
|||
C00044864
![]() |
Curcumin
|
CHEMBL116438
|
D003474
|
91 / 65 / 83 | 458 / 104 | No. 3613 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002731 | 1 / 0 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00002731 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00002731 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002731 | 7 / 37 |
Q09472 | Histone acetyltransferase p300 | Enzyme | C00002731 | 1 / 1 |
Q9NR96 | Toll-like receptor 9 | Toll-like and Il-1 receptors | C00002731 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00002731 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00002731 | 1 / 1 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00002731 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00002731 | 0 / 3 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00002731 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00002731 | 0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00002731 | 0 / 0 |
Q05655 | Protein kinase C delta type | Delta | C00002731 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00002731 | 2 / 2 |
Q04759 | Protein kinase C theta type | Delta | C00002731 | 0 / 1 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00002731 | 0 / 0 |
Q8N1Q1 | Carbonic anhydrase 13 | Lyase | C00002731 | 0 / 0 |
P20813 | Cytochrome P450 2B6 | Cytochrome P450 2B6 | C00002731 | 1 / 0 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00002731 | 0 / 0 |
P37840 | Alpha-synuclein | Unclassified protein | C00002731 | 4 / 2 |
P00918 | Carbonic anhydrase 2 | Lyase | C00002731 | 1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00002731 | 0 / 1 |
Q02156 | Protein kinase C epsilon type | Eta | C00002731 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00002731 | 1 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002731 | 0 / 1 |
P30291 | Wee1-like protein kinase | WEE serine/threonine protein kinase subfamily | C00002731 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00002731 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00002731 | 0 / 0 |
Q9UBC3 | DNA (cytosine-5)-methyltransferase 3B | Enzyme | C00002731 | 1 / 1 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00002731 | 1 / 8 |
P11387 | DNA topoisomerase 1 | Isomerase | C00002731 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00002731 | 2 / 3 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002731 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00002731 | 0 / 0 |
P05067 | Amyloid beta A4 protein | Membrane receptor | C00002731 | 2 / 2 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00002731 | 0 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00002731 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00002731 | 0 / 0 |
P68871 | Hemoglobin subunit beta | Secreted protein | C00002731 | 4 / 4 |
O43570 | Carbonic anhydrase 12 | Lyase | C00002731 | 1 / 2 |
Q9UQM7 | Calcium/calmodulin-dependent protein kinase type II subunit alpha | Camk2 | C00002731 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00002731 | 0 / 0 |
Q92993 | Histone acetyltransferase KAT5 | Enzyme | C00002731 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00002731 | 2 / 0 |
O75496 | Geminin | Unclassified protein | C00002731 | 0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00002731 | 0 / 0 |
P40763 | Signal transducer and activator of transcription 3 | Transcription Factor | C00002731 | 1 / 2 |
P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00002731 | 0 / 0 |
P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00002731 | 3 / 1 |
P11308 | Transcriptional regulator ERG | Unclassified protein | C00002731 | 1 / 2 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002731 | 1 / 2 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00002731 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00002731 | 0 / 0 |
Q99816 | Tumor susceptibility gene 101 protein | Unclassified protein | C00002731 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00002731 | 0 / 1 |
P14679 | Tyrosinase | Oxidoreductase | C00002731 | 4 / 2 |
P06276 | Cholinesterase | Hydrolase | C00002731 | 0 / 0 |
P45452 | Collagenase 3 | M10A | C00002731 | 1 / 1 |
P13726 | Tissue factor | Membrane receptor | C00002731 | 0 / 0 |
P37058 | Testosterone 17-beta-dehydrogenase 3 | Enzyme | C00002731 | 1 / 1 |
P10696 | Alkaline phosphatase, placental-like | Enzyme | C00002731 | 0 / 1 |
P56817 | Beta-secretase 1 | A1A | C00002731 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002731 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00002731 | 0 / 1 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002731 | 3 / 3 |
Q99873 | Protein arginine N-methyltransferase 1 | Enzyme | C00002731 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002731 | 2 / 2 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002731 | 0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00002731 | 1 / 0 |
P26358 | DNA (cytosine-5)-methyltransferase 1 | Transferase | C00002731 | 2 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00002731 | 0 / 0 |
P35228 | Nitric oxide synthase, inducible | Enzyme | C00002731 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002731 | 0 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00002731 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00002731 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00002731 | 4 / 3 |
P10997 | Islet amyloid polypeptide | Unclassified protein | C00002731 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002731 | 0 / 0 |
P05412 | Transcription factor AP-1 | Transcription Factor | C00002731 | 0 / 0 |
P07451 | Carbonic anhydrase 3 | Lyase | C00002731 | 0 / 0 |
Q04760 | Lactoylglutathione lyase | Enzyme | C00002731 | 0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00002731 | 1 / 1 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00002731 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002731 | 0 / 0 |
P42224 | Signal transducer and activator of transcription 1-alpha/beta | Unclassified protein | C00002731 | 3 / 3 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002731 | 1 / 1 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00002731 | 1 / 0 |
O00255 | Menin | Unclassified protein | C00002731 | 2 / 5 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002731 | 0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00002731 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
53947 | A4GALT, A14GALT, A4GALT1, Gb3S, P(k), P1, P1PK, PK | alpha 1,4-galactosyltransferase (EC:2.4.1.228) |
C00002731
|
16 | AARS, CMT2N | alanyl-tRNA synthetase (EC:6.1.1.7) |
C00002731
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00002731
|
18669 |
C00002731
|
||
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00002731
|
1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
C00002731
|
9619 | ABCG1, ABC8, WHITE1 | ATP-binding cassette, sub-family G (WHITE), member 1 |
C00002731
|
9429 | ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR1, UAQTL1 | ATP-binding cassette, sub-family G (WHITE), member 2 |
C00002731
|
31 | ACACA, ACAC, ACACAD, ACC, ACC1, ACCA | acetyl-CoA carboxylase alpha (EC:6.4.1.2 6.3.4.14) |
C00002731
|
57007 | ACKR3, CMKOR1, CXC-R7, CXCR-7, CXCR7, GPR159, RDC-1, RDC1 | atypical chemokine receptor 3 |
C00002731
|
6868 | ADAM17, ADAM18, CD156B, CSVP, NISBD, TACE | ADAM metallopeptidase domain 17 (EC:3.4.24.86) |
C00002731
|
9507 | ADAMTS4, ADAMTS-2, ADAMTS-4, ADMP-1 | ADAM metallopeptidase with thrombospondin type 1 motif, 4 (EC:3.4.24.82) |
C00002731
|
115 | ADCY9, AC9 | adenylate cyclase 9 (EC:4.6.1.1) |
C00002731
|
10551 | AGR2, AG2, GOB-4, HAG-2, PDIA17, XAG-2 | anterior gradient 2 |
C00002731
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00002731
|
9472 | AKAP6, ADAP100, ADAP6, AKAP100, PRKA6, mAKAP | A kinase (PRKA) anchor protein 6 |
C00002731
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00002731
|
226 | ALDOA, ALDA, GSD12 | aldolase A, fructose-bisphosphate (EC:4.1.2.13) |
C00002731
|
230 | ALDOC, ALDC | aldolase C, fructose-bisphosphate (EC:4.1.2.13) |
C00002731
|
353322 | ANKRD37, Lrp2bp | ankyrin repeat domain 37 |
C00002731
|
57182 | ANKRD50 | ankyrin repeat domain 50 |
C00002731
|
55139 | ANKZF1, ZNF744 | ankyrin repeat and zinc finger domain containing 1 |
C00002731
|
324 | APC, BTPS2, DP2, DP2.5, DP3, GS, PPP1R46 | adenomatous polyposis coli |
C00002731
|
351 | APP, AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN-II, PN2 | amyloid beta (A4) precursor protein |
C00002731
|
360 | AQP3, AQP-3, GIL | aquaporin 3 (Gill blood group) |
C00002731
|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00002731
|
257106 | ARHGAP30 | Rho GTPase activating protein 30 |
C00002731
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00002731
|
467 | ATF3 | activating transcription factor 3 |
C00002731
|
472 | ATM, AT1, ATA, ATC, ATD, ATDC, ATE, TEL1, TELO1 | ataxia telangiectasia mutated (EC:2.7.11.1) |
C00002731
|
126792 | B3GALT6, EDSP2, SEMDJL1, beta3GalT6 | UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6 (EC:2.4.1.134) |
C00002731
|
23621 | BACE1, ASP2, BACE, HSPC104 | beta-site APP-cleaving enzyme 1 (EC:3.4.23.46) |
C00002731
|
572 | BAD, BBC2, BCL2L8 | BCL2-associated agonist of cell death |
C00002731
|
578 | BAK1, BAK, BAK-LIKE, BCL2L7, CDN1 | BCL2-antagonist/killer 1 |
C00002731
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00002731
|
27113 | BBC3, JFY-1, JFY1, PUMA | BCL2 binding component 3 |
C00002731
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00002731
|
597 | BCL2A1, ACC-1, ACC-2, BCL2L5, BFL1, GRS, HBPA1 | BCL2-related protein A1 |
C00002731
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00002731
|
10018 | BCL2L11, BAM, BIM, BOD | BCL2-like 11 (apoptosis facilitator) |
C00002731
|
599 | BCL2L2, BCL-W, BCL2-L-2, BCLW, PPP1R51 | BCL2-like 2 |
C00002731
|
54880 | BCOR, ANOP2, MAA2, MCOPS2 | BCL6 corepressor |
C00002731
|
637 | BID, FP497 | BH3 interacting domain death agonist |
C00002731
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00002731
|
330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00002731
|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00002731
|
79444 | BIRC7, KIAP, LIVIN, ML-IAP, MLIAP, RNF50 | baculoviral IAP repeat containing 7 |
C00002731
|
834 | CASP1, ICE, IL1BC, P45 | caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36) |
C00002731
|
835 | CASP2, CASP-2, ICH1, NEDD-2, NEDD2, PPP1R57 | caspase 2, apoptosis-related cysteine peptidase (EC:3.4.22.55) |
C00002731
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00002731
|
837 | CASP4, ICE(rel)II, ICEREL-II, ICH-2, Mih1/TX, TX | caspase 4, apoptosis-related cysteine peptidase (EC:3.4.22.57) |
C00002731
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00002731
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00002731
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00002731
|
847 | CAT | catalase (EC:1.11.1.6) |
C00002731
|
55749 | CCAR1, RP11-437A18.1 | cell division cycle and apoptosis regulator 1 |
C00002731
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00002731
|
890 | CCNA2, CCN1, CCNA | cyclin A2 |
C00002731
|
891 | CCNB1, CCNB | cyclin B1 |
C00002731
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00002731
|
896 | CCND3 | cyclin D3 |
C00002731
|
898 | CCNE1, CCNE | cyclin E1 |
C00002731
|
9236 | CCPG1, CPR8 | cell cycle progression 1 |
C00002731
|
929 | CD14 | CD14 molecule |
C00002731
|
948 | CD36, BDPLT10, CHDS7, FAT, GP3B, GP4, GPIV, PASIV, SCARB3 | CD36 molecule (thrombospondin receptor) |
C00002731
|
958 | CD40, Bp50, CDW40, TNFRSF5, p50 | CD40 molecule, TNF receptor superfamily member 5 |
C00002731
|
960 | CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MIC4, Pgp1 | CD44 molecule (Indian blood group) |
C00002731
|
1604 | CD55, CR, CROM, DAF, TC | CD55 molecule, decay accelerating factor for complement (Cromer blood group) |
C00002731
|
8555 | CDC14B, CDC14B3, Cdc14B1, Cdc14B2, hCDC14B | cell division cycle 14B (EC:3.1.3.16 3.1.3.48) |
C00002731
|
991 | CDC20, CDC20A, bA276H19.3, p55CDC | cell division cycle 20 |
C00002731
|
995 | CDC25C, CDC25, PPP1R60 | cell division cycle 25C (EC:3.1.3.48) |
C00002731
|
999 | CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO | cadherin 1, type 1, E-cadherin (epithelial) |
C00002731
|
1009 | CDH11, CAD11, CDHOB, OB, OSF-4 | cadherin 11, type 2, OB-cadherin (osteoblast) |
C00002731
|
1015 | CDH17, CDH16, HPT-1, HPT1 | cadherin 17, LI cadherin (liver-intestine) |
C00002731
|
983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00002731
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00002731
|
1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00002731
|
1021 | CDK6, PLSTIRE | cyclin-dependent kinase 6 (EC:2.7.11.22) |
C00002731
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00002731
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00002731
|
1029 | CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16 | cyclin-dependent kinase inhibitor 2A |
C00002731
|
8837 | CFLAR, CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS | CASP8 and FADD-like apoptosis regulator |
C00002731
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00002731
|
1111 | CHEK1, CHK1 | checkpoint kinase 1 (EC:2.7.11.1) |
C00002731
|
11200 | CHEK2, CDS1, CHK2, HuCds1, LFS2, PP1425, RAD53, hCds1 | checkpoint kinase 2 (EC:2.7.11.1) |
C00002731
|
1147 | CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 | conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) |
C00002731
|
1185 | CLCN6, CLC-6 | chloride channel, voltage-sensitive 6 |
C00002731
|
1280 | COL2A1, ANFH, AOM, COL11A3, SEDC, STL1 | collagen, type II, alpha 1 |
C00002731
|
1282 | COL4A1, HANAC, ICH, POREN1, arresten | collagen, type IV, alpha 1 |
C00002731
|
1287 | COL4A5, ASLN, ATS, CA54 | collagen, type IV, alpha 5 |
C00002731
|
1387 | CREBBP, CBP, KAT3A, RSTS | CREB binding protein (EC:2.3.1.48) |
C00002731
|
1435 | CSF1, CSF-1, MCSF | colony stimulating factor 1 (macrophage) (EC:2.7.10.1) |
C00002731
|
1436 | CSF1R, C-FMS, CD115, CSF-1R, CSFR, FIM2, FMS, HDLS, M-CSF-R | colony stimulating factor 1 receptor (EC:2.7.10.1) |
C00002731
|
1490 | CTGF, CCN2, HCS24, IGFBP8, NOV2 | connective tissue growth factor |
C00002731
|
1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa |
C00002731
|
2919 | CXCL1, FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
C00002731
|
6387 | CXCL12, IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1, SDF1A, SDF1B | chemokine (C-X-C motif) ligand 12 |
C00002731
|
2920 | CXCL2, CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, MIP2, MIP2A, SCYB2 | chemokine (C-X-C motif) ligand 2 |
C00002731
|
3577 | CXCR1, C-C, C-C-CKR-1, CD128, CD181, CDw128a, CKR-1, CMKAR1, IL8R1, IL8RA, IL8RBA | chemokine (C-X-C motif) receptor 1 |
C00002731
|
3579 | CXCR2, CD182, CDw128b, CMKAR2, IL8R2, IL8RA, IL8RB | chemokine (C-X-C motif) receptor 2 |
C00002731
|
7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 |
C00002731
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00002731
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00002731
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00002731
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00002731
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00002731
|
27128 | CYTH4, CYT4, DJ63G5.1, PSCD4 | cytohesin 4 |
C00002731
|
1616 | DAXX, BING2, DAP6, EAP1 | death-domain associated protein |
C00002731
|
1634 | DCN, CSCD, DSPG2, PG40, PGII, PGS2, SLRR1B | decorin |
C00002731
|
1649 | DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153 | DNA-damage-inducible transcript 3 |
C00002731
|
115265 | DDIT4L, REDD2, Rtp801L | DNA-damage-inducible transcript 4-like |
C00002731
|
115817 | DHRS1, SDR19C1 | dehydrogenase/reductase (SDR family) member 1 |
C00002731
|
4189 | DNAJB9, ERdj4, MDG-1, MDG1, MST049, MSTP049 | DnaJ (Hsp40) homolog, subfamily B, member 9 |
C00002731
|
55332 | DRAM1, DRAM | DNA-damage regulated autophagy modulator 1 |
C00002731
|
1843 | DUSP1, CL100, HVH1, MKP-1, MKP1, PTPN10 | dual specificity phosphatase 1 (EC:3.1.3.16 3.1.3.48) |
C00002731
|
11221 | DUSP10, MKP-5, MKP5 | dual specificity phosphatase 10 (EC:3.1.3.16 3.1.3.48) |
C00002731
|
1847 | DUSP5, DUSP, HVH3 | dual specificity phosphatase 5 (EC:3.1.3.16 3.1.3.48) |
C00002731
|
1855 | DVL1, DVL, DVL1L1, DVL1P1 | dishevelled segment polarity protein 1 |
C00002731
|
8655 | DYNLL1, DLC1, DLC8, DNCL1, DNCLC1, LC8, LC8a, PIN, hdlc1 | dynein, light chain, LC8-type 1 |
C00002731
|
1875 | E2F5, E2F-5 | E2F transcription factor 5, p130-binding |
C00002731
|
10085 | EDIL3, DEL1 | EGF-like repeats and discoidin I-like domains 3 |
C00002731
|
1950 | EGF, HOMG4, URG | epidermal growth factor |
C00002731
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00002731
|
1958 | EGR1, AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225 | early growth response 1 |
C00002731
|
10209 | EIF1, A121, EIF-1, EIF1A, ISO1, SUI1 | eukaryotic translation initiation factor 1 |
C00002731
|
1978 | EIF4EBP1, 4E-BP1, 4EBP1, BP-1, PHAS-I | eukaryotic translation initiation factor 4E binding protein 1 |
C00002731
|
1981 | EIF4G1, EIF-4G1, EIF4F, EIF4G, EIF4GI, P220, PARK18 | eukaryotic translation initiation factor 4 gamma, 1 |
C00002731
|
1998 | ELF2, EU32, NERF, NERF-1A, NERF-1B, NERF-1a,b, NERF-2 | E74-like factor 2 (ets domain transcription factor) |
C00002731
|
2002 | ELK1 | ELK1, member of ETS oncogene family |
C00002731
|
2023 | ENO1, ENO1L1, MPB1, NNE, PPH | enolase 1, (alpha) (EC:4.2.1.11) |
C00002731
|
2033 | EP300, KAT3B, RSTS2, p300 | E1A binding protein p300 (EC:2.3.1.48) |
C00002731
|
2056 | EPO, EP, MVCD2 | erythropoietin |
C00002731
|
2064 | ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1 | v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1) |
C00002731
|
2065 | ERBB3, ErbB-3, HER3, LCCS2, MDA-BF-1, c-erbB-3, c-erbB3, erbB3-S, p180-ErbB3, p45-sErbB3, p85-sErbB3 | v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 (EC:2.7.10.1) |
C00002731
|
2067 | ERCC1, COFS4, RAD10, UV20 | excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
C00002731
|
2081 | ERN1, IRE1, IRE1P, IRE1a, hIRE1p | endoplasmic reticulum to nucleus signaling 1 (EC:2.7.11.1) |
C00002731
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00002731
|
2114 | ETS2, ETS2IT1 | v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
C00002731
|
2152 | F3, CD142, TF, TFA | coagulation factor III (thromboplastin, tissue factor) |
C00002731
|
84498 | FAM120B, CCPG, KIAA1838, PGCC1, dJ894D12.1 | family with sequence similarity 120B |
C00002731
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00002731
|
2224 | FDPS, FPPS, FPS | farnesyl diphosphate synthase (EC:2.5.1.1 2.5.1.10) |
C00002731
|
2263 | FGFR2, BBDS, BEK, BFR-1, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25 | fibroblast growth factor receptor 2 (EC:2.7.10.1) |
C00002731
|
11259 | FILIP1L, DOC-1, DOC1, GIP130, GIP90 | filamin A interacting protein 1-like |
C00002731
|
2321 | FLT1, FLT, FLT-1, VEGFR-1, VEGFR1 | fms-related tyrosine kinase 1 (EC:2.7.10.1) |
C00002731
|
2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00002731
|
2342 | FNTB, FPTB | farnesyltransferase, CAAX box, beta (EC:2.5.1.58) |
C00002731
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00002731
|
8061 | FOSL1, FRA, FRA1, fra-1 | FOS-like antigen 1 |
C00002731
|
2355 | FOSL2, FRA2 | FOS-like antigen 2 |
C00002731
|
3169 | FOXA1, HNF3A, TCF3A | forkhead box A1 |
C00002731
|
2295 | FOXF2, FKHL6, FREAC-2, FREAC2 | forkhead box F2 |
C00002731
|
2308 | FOXO1, FKH1, FKHR, FOXO1A | forkhead box O1 |
C00002731
|
2521 | FUS, ALS6, ETM4, FUS1, HNRNPP2, POMP75, TLS | fused in sarcoma |
C00002731
|
8321 | FZD1 | frizzled family receptor 1 |
C00002731
|
1647 | GADD45A, DDIT1, GADD45 | growth arrest and DNA-damage-inducible, alpha |
C00002731
|
2621 | GAS6, AXLLG, AXSF | growth arrest-specific 6 |
C00002731
|
2624 | GATA2, DCML, MONOMAC, NFE1B | GATA binding protein 2 |
C00002731
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00002731
|
2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00002731
|
2852 | GPER1, CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR | G protein-coupled estrogen receptor 1 |
C00002731
|
2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00002731
|
2941 | GSTA4, GSTA4-4, GTA4 | glutathione S-transferase alpha 4 (EC:2.5.1.18) |
C00002731
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00002731
|
283120 | H19, ASM, ASM1, BWS, D11S813E, LINC00008, NCRNA00008, PRO2605, WT2 | H19, imprinted maternally expressed transcript (non-protein coding) |
C00002731
|
8971 | H1FX, H1X | H1 histone family, member X |
C00002731
|
3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X |
C00002731
|
10767 | HBS1L, EF-1a, ERFS, HBS1, HSPC276 | HBS1-like (S. cerevisiae) |
C00002731
|
3065 | HDAC1, GON-10, HD1, RPD3, RPD3L1 | histone deacetylase 1 (EC:3.5.1.98) |
C00002731
|
3066 | HDAC2, HD2, RPD3, YAF1 | histone deacetylase 2 (EC:3.5.1.98) |
C00002731
|
8841 | HDAC3, HD3, RPD3, RPD3-2 | histone deacetylase 3 (EC:3.5.1.98) |
C00002731
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00002731
|
3017 | HIST1H2BD, H2B.1B, H2B/b, H2BFB, HIRIP2, dJ221C16.6 | histone cluster 1, H2bd |
C00002731
|
8363 | HIST1H4J, H4/e, H4F2iv, H4FE, dJ160A22.2 | histone cluster 1, H4j |
C00002731
|
554313 | HIST2H4B, H4/o | histone cluster 2, H4b |
C00002731
|
128312 | HIST3H2BB, H2Bb | histone cluster 3, H2bb |
C00002731
|
3116 | HLA-DPB2, DP2B, DPB2, DPbeta2, HLA-DP2B | major histocompatibility complex, class II, DP beta 2 (pseudogene) |
C00002731
|
3156 | HMGCR, LDLCQ3 | 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) |
C00002731
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00002731
|
693712 |
C00002731
|
||
79256 |
C00002731
|
||
3215 | HOXB5, HHO.C10, HOX2, HOX2A, HU-1, Hox2.1 | homeobox B5 |
C00002731
|
3251 | HPRT1, HGPRT, HPRT | hypoxanthine phosphoribosyltransferase 1 (EC:2.4.2.8) |
C00002731
|
3297 | HSF1, HSTF1 | heat shock transcription factor 1 |
C00002731
|
3308 | HSPA4, APG-2, HS24/P52, HSPH2, RY, hsp70, hsp70RY | heat shock 70kDa protein 4 |
C00002731
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00002731
|
3397 | ID1, ID, bHLHb24 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein |
C00002731
|
3398 | ID2, GIG8, ID2A, ID2H, bHLHb26 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
C00002731
|
3399 | ID3, HEIR-1, bHLHb25 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein |
C00002731
|
3620 | IDO1, IDO, IDO-1, INDO | indoleamine 2,3-dioxygenase 1 (EC:1.13.11.52) |
C00002731
|
3439 | IFNA1, IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@ | interferon, alpha 1 |
C00002731
|
3454 | IFNAR1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC | interferon (alpha, beta and omega) receptor 1 |
C00002731
|
3455 | IFNAR2, IFN-R, IFN-alpha-REC, IFNABR, IFNARB | interferon (alpha, beta and omega) receptor 2 |
C00002731
|
3456 | IFNB1, IFB, IFF, IFNB | interferon, beta 1, fibroblast |
C00002731
|
3458 | IFNG, IFG, IFI | interferon, gamma |
C00002731
|
56832 | IFNK, IFNT1, INFE1, RP11-27J8.1 | interferon, kappa |
C00002731
|
3479 | IGF1, IGF-I, IGF1A, IGFI | insulin-like growth factor 1 (somatomedin C) |
C00002731
|
3480 | IGF1R, CD221, IGFIR, IGFR, JTK13 | insulin-like growth factor 1 receptor (EC:2.7.10.1) |
C00002731
|
3486 | IGFBP3, BP-53, IBP3 | insulin-like growth factor binding protein 3 |
C00002731
|
3490 | IGFBP7, AGM, FSTL2, IBP-7, IGFBP-7, IGFBP-7v, IGFBPRP1, MAC25, PSF, RAMSVPS, TAF | insulin-like growth factor binding protein 7 |
C00002731
|
3543 | IGLL1, 14.1, AGM2, CD179b, IGL1, IGL5, IGLJ14.1, IGLL, IGO, IGVPB, VPREB2 | immunoglobulin lambda-like polypeptide 1 |
C00002731
|
3551 | IKBKB, IKK-beta, IKK2, IKKB, NFKBIKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) |
C00002731
|
3586 | IL10, CSIF, GVHDS, IL-10, IL10A, TGIF | interleukin 10 |
C00002731
|
3606 | IL18, IGIF, IL-18, IL-1g, IL1F4 | interleukin 18 (interferon-gamma-inducing factor) |
C00002731
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00002731
|
3558 | IL2, IL-2, TCGF, lymphokine | interleukin 2 |
C00002731
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00002731
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00002731
|
51141 | INSIG2 | insulin induced gene 2 |
C00002731
|
3684 | ITGAM, CD11B, CR3A, MAC-1, MAC1A, MO1A, SLEB6 | integrin, alpha M (complement component 3 receptor 3 subunit) |
C00002731
|
3688 | ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
C00002731
|
3713 | IVL | involucrin |
C00002731
|
3717 | JAK2, JTK10, THCYT3 | Janus kinase 2 (EC:2.7.10.2) |
C00002731
|
3718 | JAK3, JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK | Janus kinase 3 (EC:2.7.10.2) |
C00002731
|
126306 | JSRP1, JP-45, JP45 | junctional sarcoplasmic reticulum protein 1 |
C00002731
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00002731
|
3726 | JUNB, AP-1 | jun B proto-oncogene |
C00002731
|
3727 | JUND, AP-1 | jun D proto-oncogene |
C00002731
|
10242 | KCNMB2 | potassium large conductance calcium-activated channel, subfamily M, beta member 2 |
C00002731
|
3791 | KDR, CD309, FLK1, VEGFR, VEGFR2 | kinase insert domain receptor (a type III receptor tyrosine kinase) (EC:2.7.10.1) |
C00002731
|
7071 | KLF10, EGR-alpha, EGRA, TIEG, TIEG1 | Kruppel-like factor 10 |
C00002731
|
1316 | KLF6, BCD1, CBA1, COPEB, CPBP, GBF, PAC1, ST12, ZF9 | Kruppel-like factor 6 |
C00002731
|
9903 | KLHL21 | kelch-like family member 21 |
C00002731
|
54800 | KLHL24, DRE1, KRIP6 | kelch-like family member 24 |
C00002731
|
3817 | KLK2, KLK2A2, hGK-1, hK2 | kallikrein-related peptidase 2 (EC:3.4.21.35) |
C00002731
|
354 | KLK3, APS, KLK2A1, PSA, hK3 | kallikrein-related peptidase 3 (EC:3.4.21.77) |
C00002731
|
3845 | KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2 | Kirsten rat sarcoma viral oncogene homolog |
C00002731
|
81872 | KRTAP2-1, KAP2.1A, KRTAP2.1A | keratin associated protein 2-1 |
C00002731
|
8942 | KYNU | kynureninase (EC:3.7.1.3) |
C00002731
|
3937 | LCP2, SLP-76, SLP76 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
C00002731
|
3949 | LDLR, FH, FHC, LDLCQ2 | low density lipoprotein receptor |
C00002731
|
3980 | LIG3, LIG2 | ligase III, DNA, ATP-dependent (EC:6.5.1.1) |
C00002731
|
3981 | LIG4 | ligase IV, DNA, ATP-dependent (EC:6.5.1.1) |
C00002731
|
1902 | LPAR1, EDG2, GPR26, Gpcr26, LPA1, Mrec1.3, VZG1, edg-2, rec.1.3, vzg-1 | lysophosphatidic acid receptor 1 |
C00002731
|
4033 | LRMP, JAW1 | lymphoid-restricted membrane protein |
C00002731
|
54674 | LRRN3, FIGLER5, NLRR-3, NLRR3 | leucine rich repeat neuronal 3 |
C00002731
|
4049 | LTA, LT, TNFB, TNFSF1 | lymphotoxin alpha |
C00002731
|
4050 | LTB, TNFC, TNFSF3, p33 | lymphotoxin beta (TNF superfamily, member 3) |
C00002731
|
5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00002731
|
5605 | MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2 | mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) |
C00002731
|
5606 | MAP2K3, MAPKK3, MEK3, MKK3, PRKMK3, SAPKK-2, SAPKK2 | mitogen-activated protein kinase kinase 3 (EC:2.7.12.2) |
C00002731
|
6416 | MAP2K4, JNKK, JNKK1, MAPKK4, MEK4, MKK4, PRKMK4, SAPKK-1, SAPKK1, SEK1, SERK1, SKK1 | mitogen-activated protein kinase kinase 4 (EC:2.7.12.2) |
C00002731
|
4214 | MAP3K1, MAPKKK1, MEKK, MEKK_1, MEKK1, SRXY6 | mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase (EC:2.7.11.25) |
C00002731
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00002731
|
6300 | MAPK12, ERK3, ERK6, P38GAMMA, PRKM12, SAPK-3, SAPK3 | mitogen-activated protein kinase 12 (EC:2.7.11.24) |
C00002731
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00002731
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00002731
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00002731
|
5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00002731
|
4176 | MCM7, CDC47, MCM2, P1.1-MCM3, P1CDC47, P85MCM, PNAS146 | minichromosome maintenance complex component 7 (EC:3.6.4.12) |
C00002731
|
4193 | MDM2, ACTFS, HDMX, hdm2 | MDM2 oncogene, E3 ubiquitin protein ligase |
C00002731
|
4241 | MFI2, CD228, MAP97, MTF1 | antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 |
C00002731
|
4242 | MFNG | MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase (EC:2.4.1.222) |
C00002731
|
4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) |
C00002731
|
406938 | MIR146A, MIRN146, MIRN146A, miR-146a, miRNA146A | microRNA 146a |
C00002731
|
84981 | MIR22HG, C17orf91 | MIR22 host gene (non-protein coding) |
C00002731
|
4288 | MKI67, KIA, MIB-1 | marker of proliferation Ki-67 |
C00002731
|
4311 | MME, CALLA, CD10, NEP, SFE | membrane metallo-endopeptidase (EC:3.4.24.11) |
C00002731
|
4319 | MMP10, SL-2, STMY2 | matrix metallopeptidase 10 (stromelysin 2) (EC:3.4.24.22) |
C00002731
|
4322 | MMP13, CLG3, MANDP1 | matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) |
C00002731
|
4323 | MMP14, MMP-14, MMP-X1, MT-MMP, MT-MMP_1, MT1-MMP, MT1MMP, MTMMP1, WNCHRS | matrix metallopeptidase 14 (membrane-inserted) (EC:3.4.24.80) |
C00002731
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00002731
|
4314 | MMP3, CHDS6, MMP-3, SL-1, STMY, STMY1, STR1 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) |
C00002731
|
4316 | MMP7, MMP-7, MPSL1, PUMP-1 | matrix metallopeptidase 7 (matrilysin, uterine) (EC:3.4.24.23) |
C00002731
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00002731
|
10200 | MPHOSPH6, MPP, MPP-6, MPP6 | M-phase phosphoprotein 6 |
C00002731
|
4353 | MPO | myeloperoxidase (EC:1.11.2.2) |
C00002731
|
65008 | MRPL1, BM022, L1MT, MRP-L1 | mitochondrial ribosomal protein L1 |
C00002731
|
931 | MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 | membrane-spanning 4-domains, subfamily A, member 1 |
C00002731
|
4486 | MST1R, CD136, CDw136, PTK8, RON | macrophage stimulating 1 receptor (c-met-related tyrosine kinase) (EC:2.7.10.1) |
C00002731
|
2475 | MTOR, FRAP, FRAP1, FRAP2, RAFT1, RAPT1 | mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) |
C00002731
|
4597 | MVD, FP17780, MPD | mevalonate (diphospho) decarboxylase (EC:4.1.1.33) |
C00002731
|
4084 | MXD1, BHLHC58, MAD, MAD1 | MAX dimerization protein 1 |
C00002731
|
83463 | MXD3, BHLHC13, MAD3, MYX | MAX dimerization protein 3 |
C00002731
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00002731
|
10627 | MYL12A, MLCB, MRCL3, MRLC3, MYL2B | myosin, light chain 12A, regulatory, non-sarcomeric |
C00002731
|
4638 | MYLK, AAT7, KRP, MLCK, MLCK1, MLCK108, MLCK210, MSTP083, MYLK1, smMLCK | myosin light chain kinase (EC:2.7.11.18) |
C00002731
|
4671 | NAIP, BIRC1, NLRB1, psiNAIP | NLR family, apoptosis inhibitory protein |
C00002731
|
340719 | NANOS1, NOS1, SPGF12 | nanos homolog 1 (Drosophila) |
C00002731
|
79661 | NEIL1, FPG1, NEI1, hFPG1 | nei endonuclease VIII-like 1 (E. coli) (EC:4.2.99.18) |
C00002731
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00002731
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00002731
|
4791 | NFKB2, H2TF1, LYT-10, LYT10, NF-kB2, p105, p52 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
C00002731
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00002731
|
4800 | NFYA, CBF-A, CBF-B, HAP2, NF-YA | nuclear transcription factor Y, alpha |
C00002731
|
374354 | NHLRC2 | NHL repeat containing 2 |
C00002731
|
4824 | NKX3-1, BAPX2, NKX3, NKX3.1, NKX3A | NK3 homeobox 1 |
C00002731
|
4830 | NME1, AWD, GAAD, NB, NBS, NDKA, NDPK-A, NDPKA, NM23, NM23-H1 | NME/NM23 nucleoside diphosphate kinase 1 (EC:2.7.4.6) |
C00002731
|
64127 | NOD2, ACUG, BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, NOD2B, PSORAS1 | nucleotide-binding oligomerization domain containing 2 |
C00002731
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00002731
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00002731
|
4851 | NOTCH1, TAN1, hN1 | notch 1 |
C00002731
|
10577 | NPC2, EDDM1, HE1 | Niemann-Pick disease, type C2 |
C00002731
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00002731
|
10062 | NR1H3, LXR-a, LXRA, RLD-1 | nuclear receptor subfamily 1, group H, member 3 |
C00002731
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00002731
|
2908 | NR3C1, GCCR, GCR, GR, GRL | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
C00002731
|
4929 | NR4A2, HZF-3, NOT, NURR1, RNR1, TINUR | nuclear receptor subfamily 4, group A, member 2 |
C00002731
|
4928 | NUP98, ADIR2, NUP196, NUP96 | nucleoporin 98kDa |
C00002731
|
4953 | ODC1, ODC | ornithine decarboxylase 1 (EC:4.1.1.17) |
C00002731
|
4968 | OGG1, HMMH, HOGG1, MUTM, OGH1 | 8-oxoguanine DNA glycosylase (EC:4.2.99.18) |
C00002731
|
56957 | OTUD7B, CEZANNE, ZA20D1 | OTU domain containing 7B (EC:3.4.19.12) |
C00002731
|
5062 | PAK2, PAK65, PAKgamma | p21 protein (Cdc42/Rac)-activated kinase 2 (EC:2.7.11.1) |
C00002731
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00002731
|
5105 | PCK1, PEPCK-C, PEPCK1, PEPCKC | phosphoenolpyruvate carboxykinase 1 (soluble) (EC:4.1.1.32) |
C00002731
|
5111 | PCNA | proliferating cell nuclear antigen |
C00002731
|
5159 | PDGFRB, CD140B, IBGC4, IMF1, JTK12, PDGFR, PDGFR-1, PDGFR1 | platelet-derived growth factor receptor, beta polypeptide (EC:2.7.10.1) |
C00002731
|
5163 | PDK1 | pyruvate dehydrogenase kinase, isozyme 1 (EC:2.7.11.2) |
C00002731
|
5175 | PECAM1, CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM | platelet/endothelial cell adhesion molecule 1 |
C00002731
|
8864 | PER2, FASPS, FASPS1 | period circadian clock 2 |
C00002731
|
5210 | PFKFB4 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (EC:2.7.1.105 3.1.3.46) |
C00002731
|
5245 | PHB, PHB1 | prohibitin |
C00002731
|
5328 | PLAU, ATF, BDPLT5, QPD, UPA, URK, u-PA | plasminogen activator, urokinase (EC:3.4.21.73) |
C00002731
|
5329 | PLAUR, CD87, U-PAR, UPAR, URKR | plasminogen activator, urokinase receptor |
C00002731
|
130271 | PLEKHH2, PLEKHH1L | pleckstrin homology domain containing, family H (with MyTH4 domain) member 2 |
C00002731
|
5366 | PMAIP1, APR, NOXA | phorbol-12-myristate-13-acetate-induced protein 1 |
C00002731
|
56937 | PMEPA1, STAG1, TMEPAI | prostate transmembrane protein, androgen induced 1 |
C00002731
|
5423 | POLB | polymerase (DNA directed), beta (EC:2.7.7.7) |
C00002731
|
10631 | POSTN, OSF-2, OSF2, PDLPOSTN, PN, periostin | periostin, osteoblast specific factor |
C00002731
|
5467 | PPARD, FAAR, NR1C2, NUC1, NUCI, NUCII, PPARB | peroxisome proliferator-activated receptor delta |
C00002731
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00002731
|
79144 | PPDPF, C20orf149, dJ697K14.9, exdpf | pancreatic progenitor cell differentiation and proliferation factor |
C00002731
|
10105 | PPIF, CYP3, CyP-M, Cyp-D, CypD | peptidylprolyl isomerase F (EC:5.2.1.8) |
C00002731
|
5533 | PPP3CC, CALNA3, CNA3, PP2Bgamma | protein phosphatase 3, catalytic subunit, gamma isozyme (EC:3.1.3.16) |
C00002731
|
5562 | PRKAA1, AMPK, AMPKa1 | protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1 2.7.11.26 2.7.11.27 2.7.11.31) |
C00002731
|
5578 | PRKCA, AAG6, PKC-alpha, PKCA, PRKACA | protein kinase C, alpha (EC:2.7.11.13) |
C00002731
|
5580 | PRKCD, MAY1, PKCD, nPKC-delta | protein kinase C, delta (EC:2.7.10.2 2.7.11.13) |
C00002731
|
5581 | PRKCE, PKCE, nPKC-epsilon | protein kinase C, epsilon (EC:2.7.11.13) |
C00002731
|
5583 | PRKCH, PKC-L, PKCL, PRKCL, nPKC-eta | protein kinase C, eta (EC:2.7.11.13) |
C00002731
|
5591 | PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350 | protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1) |
C00002731
|
5618 | PRLR, hPRLrI | prolactin receptor |
C00002731
|
5742 | PTGS1, COX1, COX3, PCOX1, PES-1, PGG/HS, PGHS-1, PGHS1, PHS1, PTGHS | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00002731
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00002731
|
5744 | PTHLH, BDE2, HHM, PLP, PTHR, PTHRP | parathyroid hormone-like hormone |
C00002731
|
5783 | PTPN13, FAP-1, PNP1, PTP-BAS, PTP-BL, PTP1E, PTPL1, PTPLE, hPTP1E | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) (EC:3.1.3.48) |
C00002731
|
5777 | PTPN6, HCP, HCPH, HPTP1C, PTP-1C, SH-PTP1, SHP-1, SHP-1L, SHP1 | protein tyrosine phosphatase, non-receptor type 6 (EC:3.1.3.48) |
C00002731
|
5778 | PTPN7, BPTP-4, HEPTP, LC-PTP, LPTP, PTPNI | protein tyrosine phosphatase, non-receptor type 7 (EC:3.1.3.48) |
C00002731
|
5801 | PTPRR, EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ | protein tyrosine phosphatase, receptor type, R (EC:3.1.3.48) |
C00002731
|
4218 | RAB8A, MEL, RAB8 | RAB8A, member RAS oncogene family |
C00002731
|
5888 | RAD51, BRCC5, HRAD51, HsRad51, HsT16930, MRMV2, RAD51A, RECA | RAD51 recombinase |
C00002731
|
10267 | RAMP1 | receptor (G protein-coupled) activity modifying protein 1 |
C00002731
|
5914 | RARA, NR1B1, RAR | retinoic acid receptor, alpha |
C00002731
|
9770 | RASSF2, CENP-34, RASFADIN | Ras association (RalGDS/AF-6) domain family member 2 |
C00002731
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00002731
|
9584 | RBM39, CAPER, CAPERalpha, FSAP59, HCC1, RNPC2 | RNA binding motif protein 39 |
C00002731
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00002731
|
5980 | REV3L, POLZ, REV3 | REV3-like, polymerase (DNA directed), zeta, catalytic subunit (EC:2.7.7.7) |
C00002731
|
5994 | RFXAP | regulatory factor X-associated protein |
C00002731
|
6004 | RGS16, A28-RGS14, A28-RGS14P, RGS-R | regulator of G-protein signaling 16 |
C00002731
|
5999 | RGS4, RGP4, SCZD9 | regulator of G-protein signaling 4 |
C00002731
|
6000 | RGS7 | regulator of G-protein signaling 7 |
C00002731
|
9699 | RIMS2, OBOE, RAB3IP3, RIM2 | regulating synaptic membrane exocytosis 2 |
C00002731
|
6160 | RPL31, L31 | ribosomal protein L31 |
C00002731
|
6194 | RPS6, S6 | ribosomal protein S6 |
C00002731
|
6198 | RPS6KB1, PS6K, S6K, S6K-beta-1, S6K1, STK14A, p70_S6KA, p70(S6K)-alpha, p70-S6K, p70-alpha | ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) |
C00002731
|
6242 | RTKN | rhotekin |
C00002731
|
860 | RUNX2, AML3, CBF-alpha-1, CBFA1, CCD, CCD1, CLCD, OSF-2, OSF2, PEA2aA, PEBP2aA | runt-related transcription factor 2 |
C00002731
|
6319 | SCD, FADS5, MSTP008, SCD1, SCDOS | stearoyl-CoA desaturase (delta-9-desaturase) (EC:1.14.19.1) |
C00002731
|
90507 | SCRN2, Ses2 | secernin 2 |
C00002731
|
6389 | SDHA, CMD1GG, FP, PGL5, SDH1, SDH2, SDHF | succinate dehydrogenase complex, subunit A, flavoprotein (Fp) (EC:1.3.5.1) |
C00002731
|
6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00002731
|
989 | SEPT7, CDC10, CDC3, NBLA02942, SEPT7A | septin 7 |
C00002731
|
5055 | SERPINB2, HsT1201, PAI, PAI-2, PAI2, PLANH2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
C00002731
|
5268 | SERPINB5, PI5, maspin | serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
C00002731
|
5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00002731
|
6421 | SFPQ, POMP100, PSF | splicing factor proline/glutamine-rich |
C00002731
|
6425 | SFRP5, SARP3 | secreted frizzled-related protein 5 |
C00002731
|
94081 | SFXN1 | sideroflexin 1 |
C00002731
|
7779 | SLC30A1, ZNT1, ZRC1 | solute carrier family 30 (zinc transporter), member 1 |
C00002731
|
2542 | SLC37A4, G6PT1, G6PT2, G6PT3, GSD1b, GSD1c, GSD1d, TRG-19, TRG19 | solute carrier family 37 (glucose-6-phosphate transporter), member 4 |
C00002731
|
6520 | SLC3A2, 4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE | solute carrier family 3 (amino acid transporter heavy chain), member 2 |
C00002731
|
55652 | SLC48A1, HRG-1, HRG1, hHRG-1 | solute carrier family 48 (heme transporter), member 1 |
C00002731
|
23657 | SLC7A11, CCBR1, xCT | solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
C00002731
|
6579 | SLCO1A2, OATP, OATP-A, OATP1A2, SLC21A3 | solute carrier organic anion transporter family, member 1A2 |
C00002731
|
6607 | SMN2, BCD541, C-BCD541, GEMIN1, SMNC, TDRD16B | survival of motor neuron 2, centromeric |
C00002731
|
6591 | SNAI2, SLUG, SLUGH1, SNAIL2, WS2D | snail family zinc finger 2 |
C00002731
|
85028 | SNHG12, C1orf79, LINC00100, NCRNA00100, RP4-669K10.5 | small nucleolar RNA host gene 12 (non-protein coding) |
C00002731
|
6662 | SOX9, CMD1, CMPD1, SRA1 | SRY (sex determining region Y)-box 9 |
C00002731
|
6667 | SP1 | Sp1 transcription factor |
C00002731
|
6670 | SP3, SPR2 | Sp3 transcription factor |
C00002731
|
6671 | SP4, HF1B, SPR-1 | Sp4 transcription factor |
C00002731
|
6689 | SPIB, SPI-B | Spi-B transcription factor (Spi-1/PU.1 related) |
C00002731
|
6695 | SPOCK1, SPOCK, TESTICAN, TIC1 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 |
C00002731
|
6714 | SRC, ASV, SRC1, c-SRC, p60-Src | v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (EC:2.7.10.2) |
C00002731
|
6426 | SRSF1, ASF, SF2, SF2p33, SFRS1, SRp30a | serine/arginine-rich splicing factor 1 |
C00002731
|
6427 | SRSF2, PR264, SC-35, SC35, SFRS2, SFRS2A, SRp30b | serine/arginine-rich splicing factor 2 |
C00002731
|
6428 | SRSF3, SFRS3, SRp20 | serine/arginine-rich splicing factor 3 |
C00002731
|
6430 | SRSF5, HRS, SFRS5, SRP40 | serine/arginine-rich splicing factor 5 |
C00002731
|
6431 | SRSF6, B52, SFRS6, SRP55 | serine/arginine-rich splicing factor 6 |
C00002731
|
6772 | STAT1, CANDF7, ISGF-3, STAT91 | signal transducer and activator of transcription 1, 91kDa |
C00002731
|
6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) |
C00002731
|
6775 | STAT4, SLEB11 | signal transducer and activator of transcription 4 |
C00002731
|
6776 | STAT5A, MGF, STAT5 | signal transducer and activator of transcription 5A |
C00002731
|
6777 | STAT5B, STAT5 | signal transducer and activator of transcription 5B |
C00002731
|
412 | STS, ARSC, ARSC1, ASC, ES, SSDD, XLI | steroid sulfatase (microsomal), isozyme S (EC:3.1.6.2) |
C00002731
|
23213 | SULF1, HSULF-1, SULF-1 | sulfatase 1 |
C00002731
|
23512 | SUZ12, CHET9, JJAZ1 | SUZ12 polycomb repressive complex 2 subunit |
C00002731
|
10388 | SYCP2, SCP2 | synaptonemal complex protein 2 |
C00002731
|
23216 | TBC1D1, TBC, TBC1 | TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 |
C00002731
|
11138 | TBC1D8, AD3, HBLP1, TBC1D8A, VRP | TBC1 domain family, member 8 (with GRAM domain) |
C00002731
|
6934 | TCF7L2, TCF-4, TCF4 | transcription factor 7-like 2 (T-cell specific, HMG-box) |
C00002731
|
7015 | TERT, CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1, TP2, TRT, hEST2, hTRT | telomerase reverse transcriptase (EC:2.7.7.49) |
C00002731
|
7018 | TF, PRO1557, PRO2086, TFQTL1 | transferrin |
C00002731
|
7037 | TFRC, CD71, T9, TFR, TFR1, TR, TRFR, p90 | transferrin receptor |
C00002731
|
7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00002731
|
9220 | TIAF1, MAJN, SPR210 | TGFB1-induced anti-apoptotic factor 1 |
C00002731
|
7076 | TIMP1, CLGI, EPA, EPO, HCI, TIMP | TIMP metallopeptidase inhibitor 1 |
C00002731
|
7077 | TIMP2, CSC-21K, DDC8 | TIMP metallopeptidase inhibitor 2 |
C00002731
|
7113 | TMPRSS2, PP9284, PRSS10 | transmembrane protease, serine 2 (EC:3.4.21.-) |
C00002731
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00002731
|
8797 | TNFRSF10A, APO2, CD261, DR4, TRAILR-1, TRAILR1 | tumor necrosis factor receptor superfamily, member 10a |
C00002731
|
8795 | TNFRSF10B, CD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9 | tumor necrosis factor receptor superfamily, member 10b |
C00002731
|
7132 | TNFRSF1A, CD120a, FPF, MS5, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR1-d2, TNFR55, TNFR60, p55, p55-R, p60 | tumor necrosis factor receptor superfamily, member 1A |
C00002731
|
7133 | TNFRSF1B, CD120b, TBPII, TNF-R-II, TNF-R75, TNFBR, TNFR1B, TNFR2, TNFR80, p75, p75TNFR | tumor necrosis factor receptor superfamily, member 1B |
C00002731
|
8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00002731
|
8600 | TNFSF11, CD254, ODF, OPGL, OPTB2, RANKL, TRANCE, hRANKL2, sOdf | tumor necrosis factor (ligand) superfamily, member 11 |
C00002731
|
7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) |
C00002731
|
7155 | TOP2B, TOPIIB, top2beta | topoisomerase (DNA) II beta 180kDa (EC:5.99.1.3) |
C00002731
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00002731
|
8717 | TRADD, Hs.89862 | TNFRSF1A-associated via death domain |
C00002731
|
7185 | TRAF1, EBI6, MGC:10353 | TNF receptor-associated factor 1 |
C00002731
|
7186 | TRAF2, MGC:45012, TRAP, TRAP3 | TNF receptor-associated factor 2 |
C00002731
|
7187 | TRAF3, CAP-1, CAP1, CD40bp, CRAF1, IIAE5, LAP1 | TNF receptor-associated factor 3 |
C00002731
|
7189 | TRAF6, MGC:3310, RNF85 | TNF receptor-associated factor 6, E3 ubiquitin protein ligase |
C00002731
|
54210 | TREM1, CD354, TREM-1 | triggering receptor expressed on myeloid cells 1 |
C00002731
|
57761 | TRIB3, C20orf97, NIPK, SINK, SKIP3, TRB3 | tribbles pseudokinase 3 |
C00002731
|
10626 | TRIM16, EBBP | tripartite motif containing 16 |
C00002731
|
7249 | TSC2, LAM, TSC4 | tuberous sclerosis 2 |
C00002731
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00002731
|
1890 | TYMP, ECGF, ECGF1, MEDPS1, MNGIE, MTDPS1, PDECGF, TP, hPD-ECGF | thymidine phosphorylase (EC:2.4.2.4) |
C00002731
|
7316 | UBC, HMG20 | ubiquitin C |
C00002731
|
11065 | UBE2C, UBCH10, dJ447F3.2 | ubiquitin-conjugating enzyme E2C (EC:6.3.2.19) |
C00002731
|
7361 |
C00002731
|
||
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00002731
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00002731
|
54578 | UGT1A6, GNT1, HLUGP, HLUGP1, UDPGT, UDPGT_1-6, UGT1, UGT1A6S, UGT1F | UDP glucuronosyltransferase 1 family, polypeptide A6 (EC:2.4.1.17) |
C00002731
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00002731
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00002731
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00002731
|
10813 | UTP14A, NYCO16, SDCCAG16, dJ537K23.3 | UTP14, U3 small nucleolar ribonucleoprotein, homolog A (yeast) |
C00002731
|
7408 | VASP | vasodilator-stimulated phosphoprotein |
C00002731
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00002731
|
7428 | VHL, HRCA1, RCA1, VHL1, pVHL | von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase |
C00002731
|
7432 | VIP, PHM27 | vasoactive intestinal peptide |
C00002731
|
7490 | WT1, AWT1, EWS-WT1, GUD, NPHS4, WAGR, WIT-2, WT33 | Wilms tumor 1 |
C00002731
|
54739 | XAF1, BIRC4BP, HSXIAPAF1, XIAPAF1 | XIAP associated factor 1 |
C00002731
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00002731
|
7515 | XRCC1, RCC | X-ray repair complementing defective repair in Chinese hamster cells 1 |
C00002731
|
7518 | XRCC4 | X-ray repair complementing defective repair in Chinese hamster cells 4 |
C00002731
|
7520 | XRCC5, KARP-1, KARP1, KU80, KUB2, Ku86, NFIV | X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining) |
C00002731
|
2547 | XRCC6, CTC75, CTCBF, G22P1, KU70, ML8, TLAA | X-ray repair complementing defective repair in Chinese hamster cells 6 |
C00002731
|
83719 | YPEL3 | yippee-like 3 (Drosophila) |
C00002731
|
7531 | YWHAE, 14-3-3E, KCIP-1, MDCR, MDS | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide |
C00002731
|
463 | ZFHX3, ATBF1, ATBT, ZNF927 | zinc finger homeobox 3 |
C00002731
|
677 | ZFP36L1, BRF1, Berg36, ERF-1, ERF1, RNF162B, TIS11B, cMG1 | ZFP36 ring finger protein-like 1 |
C00002731
|
57336 | ZNF287, ZKSCAN13, ZSCAN45 | zinc finger protein 287 |
C00002731
|
51385 | ZNF589, SZF1 | zinc finger protein 589 |
C00002731
|
55552 | ZNF823, HSZFP36 | zinc finger protein 823 |
C00002731
|
OMIM | preferred title | UniProt |
---|---|---|
#264300 | 17-beta hydroxysteroid dehydrogenase iii deficiency |
P37058
|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#104300 | Alzheimer disease; ad |
P05067
|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#209950 | Atypical mycobacteriosis, familial |
P42224
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#613985 | Beta-thalassemia |
P68871
|
#603902 | Beta-thalassemia, dominant inclusion body type |
P68871
|
#614162 | Candidiasis, familial, 7; candf7 |
P42224
|
#604121 | Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant; adcadn |
P26358
|
#605714 | Cerebral amyloid angiopathy, app-related |
P05067
|
#114500 | Colorectal cancer; crc |
P84022
|
#127750 | Dementia, lewy body; dlb |
P37840
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#614546 | Efavirenz, poor metabolism of |
P20813
|
#133239 | Esophageal cancer |
P04637
|
#612219 | Ewing sarcoma; es |
P11308
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#140700 | Heinz body anemias |
P68871
|
#147060 | Hyper-ige recurrent infection syndrome, autosomal dominant |
P40763
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#146300 | Hypophosphatasia, adult |
P05186
|
#241510 | Hypophosphatasia, childhood |
P05186
|
#241500 | Hypophosphatasia, infantile |
P05186
|
#242860 | Immunodeficiency-centromeric instability-facial anomalies syndrome 1; icf1 |
Q9UBC3
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#211980 | Lung cancer |
P00533
P04637 |
#611162 | Malaria, susceptibility to |
P35228
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613796 | Mycobacterial and viral infections, susceptibility to, autosomal recessive |
P42224
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#614116 | Neuropathy, hereditary sensory, type ie; hsn1e |
P26358
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
#605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
#168600 | Parkinson disease, late-onset; pd |
P37840
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#613684 | Rubinstein-taybi syndrome 2; rsts2 |
Q09472
|
#603903 | Sickle cell anemia |
P68871
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#602111 | Spondyloepimetaphyseal dysplasia, missouri type |
P45452
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) P40763 (related) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35228 (related) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04637 (related) P68871 (marker) |
H00028 | Choriocarcinoma |
P00533
(related)
P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
|
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) P68871 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
P35354 (related) |
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00056 | Alzheimer's disease (AD) |
P05067
(related)
|
H01185 | Cerebral amyloid angiopathy (CAA) |
P05067
(related)
|
H00213 | Hypophosphatasia |
P05186
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00023 | Testicular cancer |
P10696
(marker)
|
H00024 | Prostate cancer |
P11308
(related)
|
H00035 | Ewing's sarcoma |
P11308
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
P45452 (related) |
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P37058
(related)
|
H00057 | Parkinson's disease (PD) |
P37840
(related)
|
H00066 | Lewy body dementia (LBD) |
P37840
(related)
|
H00107 | Other well-defined immunodeficiency syndromes |
P40763
(related)
|
H00089 | IFN-gamma/IL-12 axis |
P42224
(related)
|
H00363 | Candidiasis |
P42224
(related)
|
H01109 | Chronic mucocutaneous candidiasis (CMC) |
P42224
(related)
|
H00228 | Thalassemia |
P68871
(related)
|
H00229 | Sickle cell anemia (SCA) |
P68871
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00408 | Type I diabetes mellitus |
Q04759
(related)
|
H00504 | Rubinstein-Taybi syndrome |
Q09472
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00087 | Other humoral immunodeficiencies |
Q9UBC3
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D058186 | Acute Kidney Injury |
C00002731
|
D000236 | Adenoma |
C00002731
|
D000419 | Albuminuria |
C00002731
|
D019973 | Alcohol-Related Disorders |
C00002731
|
D000544 | Alzheimer Disease |
C00002731
|
D000647 | Amnesia |
C00002731
|
D020261 | Arsenic Poisoning |
C00002731
|
D001169 | Arthritis, Experimental |
C00002731
|
D001172 | Arthritis, Rheumatoid |
C00002731
|
D053627 | Asthenozoospermia |
C00002731
|
D050197 | Atherosclerosis |
C00002731
|
D001327 | Autoimmune Diseases |
C00002731
|
D002545 | Brain Ischemia |
C00002731
|
D001932 | Brain Neoplasms |
C00002731
|
D001943 | Breast Neoplasms |
C00002731
|
D019559 | Capillary Leak Syndrome |
C00002731
|
D002277 | Carcinoma |
C00002731
|
D018270 | Carcinoma, Ductal, Breast |
C00002731
|
D006528 | Carcinoma, Hepatocellular |
C00002731
|
D002289 | Carcinoma, Non-Small-Cell Lung |
C00002731
|
D002294 | Carcinoma, Squamous Cell |
C00002731
|
D009202 | Cardiomyopathies |
C00002731
|
D002869 | Chromosome Aberrations |
C00002731
|
D019970 | Cocaine-Related Disorders |
C00002731
|
D003072 | Cognition Disorders |
C00002731
|
D003092 | Colitis |
C00002731
|
D003103 | Coloboma |
C00002731
|
D003110 | Colonic Neoplasms |
C00002731
|
D016510 | Corneal Neovascularization |
C00002731
|
D003556 | Cystitis |
C00002731
|
D003704 | Dementia |
C00002731
|
D003924 | Diabetes Mellitus, Type 2 |
C00002731
|
D003928 | Diabetic Nephropathies |
C00002731
|
D056486 | Drug-Induced Liver Injury |
C00002731
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00002731
|
D004381 | Duodenal Ulcer |
C00002731
|
D004487 | Edema |
C00002731
|
D004751 | Enteritis |
C00002731
|
D005128 | Eye Diseases |
C00002731
|
D005234 | Fatty Liver |
C00002731
|
D005355 | Fibrosis |
C00002731
|
D005770 | Gastrointestinal Neoplasms |
C00002731
|
D005909 | Glioblastoma |
C00002731
|
D006258 | Head and Neck Neoplasms |
C00002731
|
D006331 | Heart Diseases |
C00002731
|
D016481 | Helicobacter Infections |
C00002731
|
D006461 | Hemolysis |
C00002731
|
D006470 | Hemorrhage |
C00002731
|
D015417 | Hereditary Sensory and Motor Neuropathy |
C00002731
|
D006930 | Hyperalgesia |
C00002731
|
D006937 | Hypercholesterolemia |
C00002731
|
D006949 | Hyperlipidemias |
C00002731
|
D006980 | Hyperthyroidism |
C00002731
|
D034141 | Hypoalbuminemia |
C00002731
|
D007037 | Hypothyroidism |
C00002731
|
D007249 | Inflammation |
C00002731
|
D015212 | Inflammatory Bowel Diseases |
C00002731
|
D007414 | Intestinal Neoplasms |
C00002731
|
D007674 | Kidney Diseases |
C00002731
|
D007676 | Kidney Failure, Chronic |
C00002731
|
D007859 | Learning Disorders |
C00002731
|
D007889 | Leiomyoma |
C00002731
|
D007938 | Leukemia |
C00002731
|
D008106 | Liver Cirrhosis, Experimental |
C00002731
|
D008107 | Liver Diseases |
C00002731
|
D008175 | Lung Neoplasms |
C00002731
|
D008223 | Lymphoma |
C00002731
|
D016399 | Lymphoma, T-Cell |
C00002731
|
D008545 | Melanoma |
C00002731
|
D008569 | Memory Disorders |
C00002731
|
D008630 | Mercury Poisoning |
C00002731
|
D008654 | Mesothelioma |
C00002731
|
D009062 | Mouth Neoplasms |
C00002731
|
D009069 | Movement Disorders |
C00002731
|
D009101 | Multiple Myeloma |
C00002731
|
D009134 | Muscular Atrophy, Spinal |
C00002731
|
D009203 | Myocardial Infarction |
C00002731
|
D017202 | Myocardial Ischemia |
C00002731
|
D009336 | Necrosis |
C00002731
|
D009361 | Neoplasm Invasiveness |
C00002731
|
D009369 | Neoplasms |
C00002731
|
D009374 | Neoplasms, Experimental |
C00002731
|
D009376 | Neoplasms, Hormone-Dependent |
C00002731
|
D009410 | Nerve Degeneration |
C00002731
|
D009423 | Nervous System Neoplasms |
C00002731
|
D020258 | Neurotoxicity Syndromes |
C00002731
|
D009765 | Obesity |
C00002731
|
D009845 | Oligospermia |
C00002731
|
D010003 | Osteoarthritis |
C00002731
|
D010024 | Osteoporosis |
C00002731
|
D010051 | Ovarian Neoplasms |
C00002731
|
D010190 | Pancreatic Neoplasms |
C00002731
|
D011471 | Prostatic Neoplasms |
C00002731
|
D011507 | Proteinuria |
C00002731
|
D011656 | Pulmonary Emphysema |
C00002731
|
D012128 | Respiratory Distress Syndrome, Adult |
C00002731
|
D012509 | Sarcoma |
C00002731
|
D012640 | Seizures |
C00002731
|
D018805 | Sepsis |
C00002731
|
D012878 | Skin Neoplasms |
C00002731
|
D013274 | Stomach Neoplasms |
C00002731
|
D013276 | Stomach Ulcer |
C00002731
|
D001749 | Urinary Bladder Neoplasms |
C00002731
|
D014565 | Urogenital Neoplasms |
C00002731
|